EMICIZUMAB (Hemlibra®)

Clinical Indication

Severe congenitial haemophilia A without factor VIII inhibitors

Date of classification

April 2018


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.